ViroLogic Promoting PhenoSense HIV Drug Susceptibility Test To Physicians
This article was originally published in The Gray Sheet
Executive Summary
Sales reps from ViroLogic, Inc. began calling physicians across the U.S. on Nov. 15 to promote the company's recently commercialized phenotypic HIV drug susceptibility assay, PhenoSense HIV.